Cosmo Pharmaceuticals N.V (C43) — Strategic Asset Allocation Index
Cosmo Pharmaceuticals N.V (C43) has a Strategic Asset Allocation Index of 6.5% as of June 2022. Strategic assets (PP&E of €30.40 Million plus long-term investments of €-) total €30.40 Million, measured against net assets of €469.22 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Cosmo Pharmaceuticals N.V's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Cosmo Pharmaceuticals N.V Strategic Asset Allocation Index (2016–2021)
This chart shows how Cosmo Pharmaceuticals N.V's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2022, the index stands at 6.5%, representing strategic assets of €30.40 Million against net assets of €469.22 Million EUR. For live market cap and overall valuation, see C43 stock market capitalisation.
Annual Strategic Asset Allocation Index for Cosmo Pharmaceuticals N.V (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Cosmo Pharmaceuticals N.V from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See C43 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 5.9% | €30.48 Million | €30.48 Million | €- | €512.68 Million | ▼ -1.4 pp |
| 2020 | 7.3% | €29.30 Million | €29.30 Million | €- | €400.12 Million | ▼ -0.3 pp |
| 2019 | 7.7% | €30.19 Million | €30.19 Million | €- | €393.73 Million | ▲ +1.2 pp |
| 2018 | 6.4% | €28.62 Million | €28.62 Million | €- | €444.85 Million | ▲ +0.0 pp |
| 2017 | 6.4% | €30.15 Million | €30.15 Million | €- | €470.12 Million | ▲ +1.4 pp |
| 2016 | 5.0% | €20.67 Million | €20.67 Million | €- | €415.56 Million | — |